Publicacións en colaboración con investigadores/as de Hospital Universitario Central de Asturias (5)

2015

  1. Side effects of targeted therapy

    Springer New York, pp. 377-416

2014

  1. Cabazitaxel for metastatic castration-resistant prostate cancer: Safety data from the Spanish expanded access program

    Expert Opinion on Drug Safety, Vol. 13, Núm. 9, pp. 1165-1173

2009

  1. Comprehensive lung injury pathology induced by mTOR inhibitors

    Clinical and Translational Oncology, Vol. 11, Núm. 8, pp. 499-510

2007

  1. Cyclooxygenase-2 (COX-2): A molecular target in prostate cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 11, pp. 694-702

1983

  1. Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 6, Núm. 1, pp. 35-38